```html

Acute Hepatitis – Comprehensive Medical Guide

Overview

Acute hepatitis is a sudden inflammation of the liver that develops over days to weeks and typically resolves within six months. It can be caused by viral infections, toxins, medications, or autoimmune processes. While anyone can develop acute hepatitis, the condition is most common in:

• Adults 20‑50 years old (peak incidence for viral hepatitis)
• People with recent travel to endemic regions
• Individuals taking high‑dose acetaminophen or certain prescription drugs

Globally, acute viral hepatitis accounts for an estimated 1.4 million cases per year, with hepatitis A and B responsible for the majority of symptomatic infections (WHO, 2023). In the United States, the CDC reports about 30,000 acute hepatitis A cases annually, while acute hepatitis B incidence has declined to 3.5 per 100,000 persons thanks to vaccination programs (CDC, 2022).

Symptoms

Symptoms may appear 2‑6 weeks after exposure (shorter with toxins) and can range from mild to severe. Not every person experiences every symptom.

General symptoms

• Fatigue – persistent tiredness that interferes with daily activities.
• Fever – low‑grade (≤38 °C) to high‑grade (>38 °C).
• Loss of appetite – may lead to weight loss.
• Nausea and vomiting – occasionally with bile‑stained vomitus.
• Abdominal discomfort – especially in the right upper quadrant.

Specific hepatic signs

• Jaundice – yellowing of the skin and sclerae; usually appears when bilirubin > 2 mg/dL.
• Dark urine – due to bilirubin excretion.
• Pale, clay‑colored stools – lack of bile pigments.
• Right‑upper‑quadrant tenderness – the liver capsule becomes inflamed.
• Enlarged liver (hepatomegaly) – may be palpable on physical exam.

Severe or atypical manifestations

• Confusion or altered mental status (hepatic encephalopathy).
• Bleeding tendencies (prolonged PT/INR) due to impaired clotting factor synthesis.
• Acute liver failure – rapid loss of liver function within days to weeks.

Causes and Risk Factors

Infectious causes

• Hepatitis A virus (HAV) – fecal‑oral transmission; outbreaks linked to contaminated food or water.
• Hepatitis B virus (HBV) – blood and sexual exposure; the incubation period is 1‑4 months.
• Hepatitis C virus (HCV) – primarily causes chronic disease, but acute infection can occur after needle sharing or transfusion.
• Hepatitis E virus (HEV) – especially prevalent in low‑resource settings with unsafe water.
• Other viruses – Epstein‑Barr, cytomegalovirus, and adenovirus can cause hepatitis, mainly in immunocompromised hosts.

Toxic and drug‑induced hepatitis

• Acetaminophen overdose – the most common cause of acute liver failure in the U.S. (≈ 30,000 hospitalizations per year).<sup>[1]</sup>
• Herbal and dietary supplements – e.g., kava, green tea extract, and pyrrolizidine alkaloids.
• Prescription medications – isoniazid, methotrexate, amoxicillin‑clavulanate, and certain antiretrovirals.

Autoimmune hepatitis

A rare condition where the immune system attacks liver cells, often presenting with high serum aminotransferases and autoantibodies.

Risk factors

• Recent travel to endemic regions (HAV, HEV).
• Unprotected sexual activity or sharing needles (HBV, HCV).
• Chronic alcohol use – synergistic hepatotoxicity.
• Pre‑existing liver disease (e.g., fatty liver) – lower threshold for injury.
• Use of over‑the‑counter pain relievers, especially acetaminophen > 4 g/day.

Diagnosis

Early recognition relies on a combination of history, physical exam, and targeted laboratory/imaging studies.

Laboratory tests

• Liver enzymes – Alanine aminotransferase (ALT) and Aspartate aminotransferase (AST) often rise > 10‑50 × upper limit of normal (ULN).
• Bilirubin – total bilirubin elevation corroborates jaundice.
• Alkaline phosphatase (ALP) & γ‑GT – may be modestly elevated.
• Coagulation profile – Prothrombin time (PT)/INR assesses synthetic function; INR > 1.5 suggests severe disease.
• Serologic markers – HAV IgM, HBsAg & HBcIgM, HCV RNA, HEV IgM to identify viral etiology.
• Autoantibodies – ANA, SMA, LKM‑1 for autoimmune hepatitis.

Imaging

• Abdominal ultrasound – evaluates liver size, echotexture, and rules out biliary obstruction.
• CT or MRI – reserved for complicated cases (e.g., suspected necrosis or vascular thrombosis).

Liver biopsy

Rarely needed in acute settings; may be performed when diagnosis is unclear, especially to confirm autoimmune hepatitis or drug‑induced injury.

Treatment Options

Therapy is directed at the underlying cause, supportive care, and preventing complications.

Viral hepatitis

• HAV & HEV – usually self‑limited; supportive care (hydration, rest). Hospitalization for severe jaundice or coagulopathy.
• HBV – most acute infections resolve spontaneously, but antiviral therapy (e.g., entecavir, tenofovir) is indicated for fulminant disease or immunocompromised patients.
• HCV – acute infection rarely treated; if persistent after 6 months, standard direct‑acting antiviral (DAA) regimens are initiated.

Drug‑induced/toxic hepatitis

• Acetaminophen overdose – N‑acetylcysteine (NAC) is most effective when given within 8‑10 hours; standard protocol: 150 mg/kg IV over 1 hour, then 50 mg/kg over 4 hours, followed by 100 mg/kg over 16 hours.
• Discontinue offending agent promptly.
• Consider liver‑protective agents (e.g., silymarin) only as adjuncts—evidence remains limited.

Autoimmune hepatitis

• First‑line: prednisone (30‑60 mg/day) ± azathioprine.
• Goal is biochemical remission (normal ALT/AST) and tapering steroids to minimize side effects.

Supportive care

• Intravenous fluids to maintain euvolemia.
• Anti‑emetics (ondansetron, metoclopramide) for nausea.
• Ursodeoxycholic acid in cholestatic presentations (evidence modest).
• Vitamin K 10 mg daily for coagulopathy, unless contraindicated.

Liver transplantation

Reserved for acute liver failure with encephalopathy, INR > 2.0, or refractory metabolic derangements. Survival exceeds 80 % with timely transplantation (Cleveland Clinic, 2022).

Living with Acute Hepatitis

Even when the disease resolves, patients often need guidance to recover fully and avoid re‑injury.

Daily management tips

• Rest – aim for 7‑9 hours of sleep; avoid strenuous activity for 2‑4 weeks.
• Nutrition – small, frequent meals low in fat; incorporate high‑quality protein (lean poultry, legumes) to support regeneration.
• Hydration – at least 2 L of water daily unless fluid‑restricted.
• Avoid alcohol – complete abstinence for at least 3 months after symptom resolution.
• Medication review – keep a list of all over‑the‑counter and prescription drugs; discuss any new medication with a provider before use.
• Follow‑up labs – repeat LFTs every 1‑2 weeks until normalized, then monthly for 3 months.
• Vaccinations – if hepatitis A or B caused the episode, ensure completion of the vaccine series to prevent reinfection.

Psychosocial considerations

Acute hepatitis can cause anxiety about liver health and contagion. Encourage patients to:

• Seek counseling if they feel isolated.
• Join support groups (e.g., Hepatitis Foundation).
• Practice good hand hygiene and safe food handling to limit spread (especially for HAV/HEV).

Prevention

Many forms of acute hepatitis are preventable with public health measures and personal habits.

Vaccination

• Hepatitis A vaccine – two‑dose series, 6‑12 months apart; 95 % protective efficacy.
• Hepatitis B vaccine – three‑dose schedule (0, 1, 6 months); recommended for all infants, health‑care workers, travelers, and people with risk factors.

Safe practices

• Hand‑washing with soap after restroom use and before preparing food.
• Consume only filtered or boiled water in endemic areas.
• Avoid raw or undercooked shellfish in areas with known HAV outbreaks.
• Use condoms and avoid sharing needles to reduce HBV/HCV transmission.
• Limit alcohol intake (< 14 units/week for men, < 7 units/week for women) to lower baseline liver stress.

Medication safety

• Never exceed 4 g of acetaminophen per day (or lower if you have liver disease).
• Read medication labels for “contains acetaminophen” warnings.
• Consult a pharmacist before combining herbal supplements with prescription drugs.

Complications

When acute hepatitis is not recognized or treated promptly, several serious complications may arise.

• Acute liver failure (ALF) – rapid loss of synthetic function, hepatic encephalopathy, and a mortality rate of 30‑50 % without transplantation.
• Coagulopathy – prolonged PT/INR leading to bleeding; may require plasma or vitamin K.
• Cholestasis – persistent jaundice and pruritus lasting > 6 months, occasionally progressing to chronic biliary disease.
• Secondary bacterial infections – especially spontaneous bacterial peritonitis in cases with ascites.
• Renal dysfunction – hepatorenal syndrome in severe ALF.

When to Seek Emergency Care

---

Sources: Mayo Clinic. Hepatitis A, B, C. 2023; CDC. Hepatitis Surveillance Data, 2022; WHO. Hepatitis Fact Sheets, 2023; NIH National Institute of Diabetes and Digestive and Kidney Diseases. Acute Liver Failure. 2022; Cleveland Clinic. Liver Transplant Outcomes, 2022; Journal of Clinical Toxicology. Acetaminophen Toxicity Review, 2021.

```